Collegium Pharmaceutical, Inc. (COLL) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 57.11M | 123.05M | 78.44M | 72.44M | 55.4M | 84.64M | -9M | 67.4M | 61.94M | 73.34M | 74.02M | 99.72M | 27.67M | 66.33M | 42.77M | 40.45M | -25.32M | 36.2M | 17.25M | 29.54M |
| Operating CF Margin % | 29.51% | 59.89% | 37.47% | 38.53% | 31.16% | 46.52% | -5.65% | 46.39% | 42.74% | 48.98% | 54.14% | 73.57% | 19.11% | 51.17% | 33.67% | 32.74% | -30.23% | 132.29% | 21.88% | 35.61% |
| Operating CF Growth % | 3.1% | 45.37% | 971.63% | 7.48% | -10.56% | 15.42% | -112.16% | -32.41% | 123.83% | 10.57% | 73.06% | 146.53% | 209.31% | 83.23% | 147.88% | 36.96% | -223.07% | 60.33% | -49.52% | -32.65% |
| Net Income | 14.5M | 16.96M | 31.51M | 11.98M | 2.42M | 12.54M | 9.34M | 19.61M | 27.71M | 31.94M | 20.63M | 13.01M | -17.43M | -7.2M | 457K | -5.19M | -13.07M | -25.03M | 8.05M | 72.84M |
| Depreciation & Amortization | 55.3M | 59.45M | 56.51M | 56.61M | 56.56M | 56.51M | 41.75M | 35.47M | 35.43M | 35.46M | 37.15M | 38.25M | 38.28M | 43.1M | 37.95M | 38.16M | 19.64M | 17.22M | 17.24M | 17.22M |
| Stock-Based Compensation | 10.88M | 9.75M | 9.81M | 10.82M | 11.52M | 7.6M | 7.32M | 10.01M | 7.47M | 7M | 7.03M | 0 | 6.04M | 5.67M | 0 | 5.69M | 6.13M | 4.91M | 5.95M | 6.52M |
| Deferred Taxes | -968K | -10.07M | -12.13M | -2.91M | -539K | -10.16M | -8.73M | -3.51M | -4.41M | -338K | -1.13M | -636K | -46K | -1.08M | 2.1M | -3.37M | -6.04M | -15.02M | -377K | -62.65M |
| Other Non-Cash Items | 1.26M | 13.13M | 1.25M | 1.81M | 1.14M | 1.35M | 5.29M | 8.04M | 1.34M | 1.37M | 1.51M | 9.23M | 25.69M | 2.28M | 7.84M | 2.79M | 1.07M | 777K | 837K | 884K |
| Working Capital Changes | -23.85M | 33.83M | -8.5M | -5.86M | -15.7M | 16.81M | -63.95M | -2.22M | -5.62M | -2.1M | 8.83M | 39.87M | -24.86M | 23.55M | -5.58M | 2.37M | -33.05M | 53.34M | -14.44M | -5.28M |
| Change in Receivables | -17.43M | 22.62M | -20.93M | 15.68M | -170K | 106K | -190K | -9.16M | 4.83M | 2.33M | -14.37M | 11.65M | 3.99M | 12.28M | 2.1M | -31.16M | -5.01M | 43.16M | -58.9M | 3.06M |
| Change in Inventory | -1.83M | -2.86M | 96K | -930K | -1.66M | 2.47M | 6.99M | 3.41M | 1.06M | 1.79M | -8.1M | 6.87M | 13.61M | 18.15M | 13.12M | 16.68M | 330K | -36K | 2.24M | -4.1M |
| Change in Payables | -3.83M | 3.04M | -3.28M | -6.96M | 13.92M | 810K | -5.94M | -3.61M | -2.54M | 4.96M | 1.18M | -573K | -502K | -4.14M | 1.01M | 2.78M | -350K | -3.54M | 186K | -1.12M |
| Cash from Investing | 1.63M | -20.07M | -30.87M | -2.92M | -9.68M | -11.76M | -248.96M | -8.91M | -18.13M | -25.1M | -3.82M | -41.72M | -176K | -940K | -113K | -461K | -572.18M | -515K | -276K | -725K |
| Capital Expenditures | -270K | -689K | -188K | -65K | -798K | -570K | -244K | -270K | -568K | -164K | -65K | -56K | -176K | -940K | -113K | -461K | -108K | -515K | -276K | -725K |
| CapEx % of Revenue | 0.14% | 0.34% | 0.09% | 0.03% | 0.45% | 0.31% | 0.15% | 0.19% | 0.39% | 0.11% | 0.05% | 0.04% | 0.12% | 0.73% | 0.09% | 0.37% | 0.13% | 1.88% | 0.35% | 0.87% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -572.07M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | -267.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -21.34M | -21.82M | -14.82M | -48.37M | -25.24M | -41.28M | 149.03M | -114.21M | -54.15M | -67.83M | -95.41M | -45.24M | 68.3M | -25.82M | -31.25M | -23.97M | 517.76M | -42.5M | -26.51M | -8.83M |
| Debt Issued (Net) | -7.25M | -21.95M | -16.15M | -16.15M | -16.15M | -16.15M | 148.55M | -45.83M | -45.83M | -45.83M | -45.83M | -46.27M | 72.02M | -25M | -25M | -25M | 517.68M | -12.5M | -12.5M | -12.5M |
| Equity Issued (Net) | 1.34M | 985K | 2.29M | -24.8M | 0 | -25.02M | 0 | -29.28M | 0 | -25M | -50M | 1.25M | 0 | -7.64M | -6.15M | 0 | 0 | -32.34M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -25.1M | 0 | -25.02M | 0 | -35M | 0 | -25M | -50M | 0 | 0 | -7.64M | -6.42M | 0 | 0 | -32.34M | 0 | 0 |
| Other Financing | -15.43M | -861K | -964K | -7.43M | -9.09M | -106K | 478K | -39.09M | -8.31M | 3.01M | 421K | -220K | -3.72M | 6.82M | -106K | 1.03M | 82K | 2.34M | -14.01M | 3.67M |
| Net Change in Cash | 37.4M | 81.16M | 32.75M | 21.15M | 20.48M | 31.61M | -108.93M | -55.72M | -10.34M | -19.59M | -25.22M | 14.27M | 95.79M | 39.56M | 11.4M | 16.02M | -79.73M | -6.82M | -9.53M | 19.98M |
| Free Cash Flow | 56.84M | 122.36M | 78.25M | 72.37M | 54.6M | 84.07M | -9.24M | 67.13M | 61.37M | 73.17M | 73.95M | 99.67M | 27.5M | 65.39M | 42.66M | 39.99M | -25.42M | 35.68M | 16.98M | 28.81M |
| FCF Margin % | 29.37% | 59.56% | 37.38% | 38.5% | 30.72% | 46.21% | -5.8% | 46.21% | 42.35% | 48.87% | 54.1% | 73.53% | 18.99% | 50.44% | 33.58% | 32.37% | -30.36% | 130.41% | 21.53% | 34.74% |
| FCF Growth % | 4.11% | 45.54% | 946.59% | 7.81% | -11.03% | 14.9% | -112.5% | -32.65% | 123.2% | 11.91% | 73.37% | 149.23% | 208.15% | 83.24% | 151.24% | 38.81% | -226.22% | 69.15% | -46.57% | -33.04% |
| FCF per Share | 1.42 | 3.08 | 1.98 | 1.85 | 1.66 | 2.10 | -0.23 | 1.66 | 1.48 | 1.77 | 1.76 | 2.33 | 0.80 | 1.95 | 1.23 | 1.18 | -0.75 | 1.05 | 0.47 | 0.70 |
| FCF Conversion (FCF/Net Income) | 3.94x | 7.25x | 2.49x | 6.05x | 22.92x | 6.75x | -0.96x | 3.44x | 2.23x | 2.30x | 3.59x | 7.67x | -1.59x | -9.21x | 93.59x | -7.79x | 1.94x | -1.45x | 2.14x | 0.41x |
| Interest Paid | 0 | 0 | 0 | 13.85M | 21.69M | 15.22M | 17.67M | 0 | 17.47M | 15.58M | 20.49M | 0 | 19.5M | 17.25M | 0 | 11.92M | 5.83M | 3.04M | 5.22M | 3.6M |
| Taxes Paid | 0 | 0 | 0 | 29.82M | 2.46M | -51.47M | 15.59M | 0 | 173K | 6.91M | 7.28M | 0 | 743K | 363K | 0 | 4.66M | 2.11M | 676K | 1.45M | 458K |